Home » Analyst Articles – US

AvePoint (NASDAQ:AVPT) PT Raised to $18.00 at Northland Securities

AvePoint (NASDAQ:AVPT) PT Raised to $18.00 at Northland Securities

AvePoint (NASDAQ:AVPT – Get Free Report) had its price target increased by equities researchers at Northland Securities from $12.00 to $18.00 in a report issued on Monday, Benzinga reports. The firm currently has an “outperform”... More of this article »
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Increased to $66.00 by Analysts at HC Wainwright

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Increased to $66.00 by Analysts at HC Wainwright

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its price objective raised by equities research analysts at HC Wainwright from $58.00 to $66.00 in a note issued to investors on Monday, Benzinga reports. The brokerage... More of this article »
Bank of America Increases Kirby (NYSE:KEX) Price Target to $138.00

Bank of America Increases Kirby (NYSE:KEX) Price Target to $138.00

Kirby (NYSE:KEX – Get Free Report) had its target price boosted by investment analysts at Bank of America from $131.00 to $138.00 in a report released on Monday, Benzinga reports. The firm currently has a “buy” rating... More of this article »
Cabaletta Bio (NASDAQ:CABA) Earns Buy Rating from Stifel Nicolaus

Cabaletta Bio (NASDAQ:CABA) Earns Buy Rating from Stifel Nicolaus

Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Stifel Nicolaus in a research note issued to investors on Monday, Benzinga reports. They... More of this article »
Aerovate Therapeutics’ (AVTE) “Neutral” Rating Reiterated at Guggenheim

Aerovate Therapeutics’ (AVTE) “Neutral” Rating Reiterated at Guggenheim

Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report)‘s stock had its “neutral” rating reiterated by Guggenheim in a research note issued to investors on Monday, MarketBeat Ratings reports. Several other equities... More of this article »
Truist Financial Reiterates “Buy” Rating for Corcept Therapeutics (NASDAQ:CORT)

Truist Financial Reiterates “Buy” Rating for Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Truist Financial in a report issued on Monday, Benzinga reports. They presently have a $65.00... More of this article »
Robert W. Baird Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $39.00

Robert W. Baird Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $39.00

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) had its target price upped by equities research analysts at Robert W. Baird from $34.00 to $39.00 in a research report issued on Monday, Benzinga reports. The brokerage currently... More of this article »
Viking Therapeutics’ (VKTX) “Buy” Rating Reiterated at Truist Financial

Viking Therapeutics’ (VKTX) “Buy” Rating Reiterated at Truist Financial

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Truist Financial in a report issued on Monday, Benzinga reports. They presently have... More of this article »
Barclays Raises Westlake (NYSE:WLK) Price Target to $162.00

Barclays Raises Westlake (NYSE:WLK) Price Target to $162.00

Westlake (NYSE:WLK – Get Free Report) had its price objective boosted by equities research analysts at Barclays from $160.00 to $162.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm... More of this article »
United Bankshares’ (UBSI) Market Perform Rating Reiterated at Keefe, Bruyette & Woods

United Bankshares’ (UBSI) Market Perform Rating Reiterated at Keefe, Bruyette & Woods

United Bankshares (NASDAQ:UBSI – Get Free Report)‘s stock had its “market perform” rating reiterated by investment analysts at Keefe, Bruyette & Woods in a research note issued to investors on Monday, Benzinga... More of this article »
RH (NYSE:RH) Given New $226.00 Price Target at The Goldman Sachs Group

RH (NYSE:RH) Given New $226.00 Price Target at The Goldman Sachs Group

RH (NYSE:RH – Get Free Report) had its target price reduced by stock analysts at The Goldman Sachs Group from $264.00 to $226.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage... More of this article »
Barclays Cuts PG&E (NYSE:PCG) Price Target to $21.00

Barclays Cuts PG&E (NYSE:PCG) Price Target to $21.00

PG&E (NYSE:PCG – Get Free Report) had its target price reduced by equities researchers at Barclays from $22.00 to $21.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “overweight”... More of this article »
The Goldman Sachs Group Trims Macerich (NYSE:MAC) Target Price to $12.50

The Goldman Sachs Group Trims Macerich (NYSE:MAC) Target Price to $12.50

Macerich (NYSE:MAC – Get Free Report) had its target price dropped by analysts at The Goldman Sachs Group from $14.00 to $12.50 in a report issued on Monday, Benzinga reports. The firm presently has a “sell” rating... More of this article »
Progressive (NYSE:PGR) Given New $232.00 Price Target at Citigroup

Progressive (NYSE:PGR) Given New $232.00 Price Target at Citigroup

Progressive (NYSE:PGR – Get Free Report) had its target price upped by analysts at Citigroup from $230.00 to $232.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “neutral” rating... More of this article »
ASML (NASDAQ:ASML) Price Target Increased to $1,185.00 by Analysts at Wells Fargo & Company

ASML (NASDAQ:ASML) Price Target Increased to $1,185.00 by Analysts at Wells Fargo & Company

ASML (NASDAQ:ASML – Get Free Report) had its price target lifted by investment analysts at Wells Fargo & Company from $1,150.00 to $1,185.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently... More of this article »
JPMorgan Chase & Co. Trims Jabil (NYSE:JBL) Target Price to $145.00

JPMorgan Chase & Co. Trims Jabil (NYSE:JBL) Target Price to $145.00

Jabil (NYSE:JBL – Get Free Report) had its price objective lowered by JPMorgan Chase & Co. from $155.00 to $145.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,150.00 at JPMorgan Chase & Co.

Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,150.00 at JPMorgan Chase & Co.

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target lifted by equities research analysts at JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a research report issued on Monday, Benzinga reports.... More of this article »
HC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)

HC Wainwright Reiterates Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They presently have a... More of this article »
Keefe, Bruyette & Woods Reaffirms “Outperform” Rating for AXIS Capital (NYSE:AXS)

Keefe, Bruyette & Woods Reaffirms “Outperform” Rating for AXIS Capital (NYSE:AXS)

AXIS Capital (NYSE:AXS – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at Keefe, Bruyette & Woods in a report issued on Monday, Benzinga reports. They presently have... More of this article »
JPMorgan Chase & Co. Cuts Yatsen (NYSE:YSG) Price Target to $3.80

JPMorgan Chase & Co. Cuts Yatsen (NYSE:YSG) Price Target to $3.80

Yatsen (NYSE:YSG – Get Free Report) had its target price cut by equities researchers at JPMorgan Chase & Co. from $4.70 to $3.80 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “neutral”... More of this article »
Charles Schwab (NYSE:SCHW) Rating Reiterated by Keefe, Bruyette & Woods

Charles Schwab (NYSE:SCHW) Rating Reiterated by Keefe, Bruyette & Woods

Charles Schwab (NYSE:SCHW – Get Free Report)‘s stock had its “market perform” rating reaffirmed by Keefe, Bruyette & Woods in a research report issued to clients and investors on Monday, Benzinga reports.... More of this article »
PagSeguro Digital (NYSE:PAGS) PT Raised to $15.00

PagSeguro Digital (NYSE:PAGS) PT Raised to $15.00

PagSeguro Digital (NYSE:PAGS – Get Free Report) had its target price hoisted by JPMorgan Chase & Co. from $14.00 to $15.00 in a report issued on Monday, Benzinga reports. The brokerage currently has a “neutral”... More of this article »
Shattuck Labs (NASDAQ:STTK) Price Target Lowered to $9.00 at Citigroup

Shattuck Labs (NASDAQ:STTK) Price Target Lowered to $9.00 at Citigroup

Shattuck Labs (NASDAQ:STTK – Get Free Report) had its target price lowered by equities researchers at Citigroup from $10.00 to $9.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “buy”... More of this article »
First Interstate BancSystem (NASDAQ:FIBK) Receives “Market Perform” Rating from Keefe, Bruyette & Woods

First Interstate BancSystem (NASDAQ:FIBK) Receives “Market Perform” Rating from Keefe, Bruyette & Woods

First Interstate BancSystem (NASDAQ:FIBK – Get Free Report)‘s stock had its “market perform” rating reiterated by investment analysts at Keefe, Bruyette & Woods in a report issued on Monday, Benzinga reports.... More of this article »
Co-Diagnostics (NASDAQ:CODX) Rating Reiterated by HC Wainwright

Co-Diagnostics (NASDAQ:CODX) Rating Reiterated by HC Wainwright

Co-Diagnostics (NASDAQ:CODX – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a report released on Monday, Benzinga reports. They presently have a $2.00 target... More of this article »